syngo.CT Brain Hemorrhage

by Siemens Healthineers  · Based in United States → — We pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably.
Emergency Medicine Neurology Radiology

Subscription-based
Regulatory Status Disclosed

Overview

syngo.CT Brain Hemorrhage is an advanced AI-powered software solution developed by Siemens Medical Solutions USA, designed to assist radiologists in the rapid identification and prioritization of suspected intracranial hemorrhage (ICH) and subarachnoid hemorrhage (SAH) on non-contrast head CT examinations.

This image-processing software utilizes artificial intelligence algorithms to analyze CT images and flag cases for earlier review, thereby improving workflow efficiency in emergency settings. It operates as a notification-only tool, making case-level output available to a CT scanner or other PACS system for worklist prioritization. It is important to note that the output is intended for informational purposes only and is not for diagnostic use; the device does not alter the original medical image and is not intended to be used as a standalone diagnostic device.

Additionally, a related application, syngo.CT DE Brain Hemorrhage, leverages dual-energy CT to generate virtual non-contrast images from contrast-enhanced scans, potentially avoiding the need for a separate unenhanced CT scan. This functionality aids in the visualization of iodine concentration and distribution in the brain, helping to differentiate hemorrhage from iodine uptaking lesions or post-interventional bleeding from transient iodine uptake.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered detection of acute intracranial hemorrhage (ICH) and subarachnoid hemorrhage (SAH)
  • Prioritization of CT scans for urgent review in radiology workflow
  • Generates virtual non-contrast images from contrast-enhanced dual energy scans (syngo.CT DE Brain Hemorrhage)
  • Aids in differentiation of hemorrhage and iodine uptaking lesions (syngo.CT DE Brain Hemorrhage)
  • Supports analysis of DICOM images from Siemens and other vendors
  • Compatible with SOMARIS-X and syngo.via platforms
  • Notification-only tool; does not alter original medical images
  • High sensitivity (95.0% for ICH, 86.1% for SAH) and specificity (93.1% for ICH, 85.2% for SAH)
  • Average processing time of 13.34 seconds per case

Use Cases

  • Accelerating workflow for radiologists in emergency departments
  • Assisting in the rapid identification of acute intracranial and subarachnoid hemorrhages
  • Prioritizing cases of suspected brain hemorrhage for earlier clinical review
  • Reducing the need for additional non-contrast CT scans by creating virtual non-contrast images from dual-energy data
  • Differentiating post-interventional bleeding from transient iodine uptake in neuro-interventional procedures

What Physicians Need to Know

Stroke Detection Speed
syngo.CT Brain Hemorrhage, as part of the CT Neuro Engine, contributes to reducing door-to-needle times in stroke diagnosis by quickly answering key diagnostic questions.
Brain CT Analysis
syngo.CT Brain Hemorrhage is a software application used with CT imaging to help detect and evaluate brain hemorrhages. It provides automated tools to identify and assess hemorrhagic lesions, potentially improving diagnostic accuracy and efficiency. The application can generate a virtual non-contrast image from a contrast-enhanced dual-energy scan, potentially avoiding a second scan. It also assists in visualizing iodine concentration and distribution in the brain, aiding in the differentiation of hemorrhage and iodine-uptaking lesions. A recent study indicated that the AI software syngo.CT Brain Hemorrhage VB60 offered a sensitivity of 93.6% and a negative predictive value of 99.2% for intracranial hemorrhage detection on non-contrast cranial CT scans.
Large Vessel Occlusion Detection
While syngo.CT Brain Hemorrhage focuses on hemorrhage, other components of the Siemens Healthineers stroke solution, such as syngo.CT Dynamic Angio, can visualize collateral status and measure occlusion length in stroke cases. Siemens Healthineers also offers syngo.CT LVO Detection, a deep learning algorithm that flags potential large-vessel occlusions with an on-screen alert.
Triage Prioritization Speed
The high negative predictive value (99.2%) of syngo.CT Brain Hemorrhage VB60 suggests its potential for workload reduction and prioritizing clinically relevant cases, especially during staffing limitations.
ASPECTS Score Automation
While syngo.CT Brain Hemorrhage focuses on hemorrhage, syngo.CT ASPECTS is a related application that automatically calculates the ASPECT score from non-contrast CT head scans and highlights affected brain regions. This automation provides consistent results and is always available for urgent situations.
Mobile Notification System
syngo.via WebViewer allows medical professionals to access high-quality multimodality images from anywhere, including on mobile devices, enabling flexible viewing and reading. This can support medical on-call or emergency services.
Physician Tip

syngo.CT Brain Hemorrhage can help differentiate between hemorrhage and iodine uptake, which is particularly useful in post-interventional stroke cases to distinguish bleeding from transient iodine. The ability to generate virtual non-contrast images from contrast-enhanced scans can reduce the need for additional scans, optimizing patient workflow. The high negative predictive value of the AI software can assist in ruling out intracranial hemorrhage with high reliability, potentially aiding in workload management and case prioritization.

syngo.CT Brain Hemorrhage is part of the broader syngo.via platform, which offers a comprehensive suite of applications for various clinical fields, including neurology. syngo.via is built on a client-server architecture, allowing for modular licensing and expansion. It integrates with CT scanners like SOMATOM Edge eco and SOMATOM Definition Edge. The syngo.via platform supports automated pre-processing steps, pre-fetching of prior examinations, and direct sending of results to PACS.

Details

Category Neurology AI, Radiology & Imaging AI
Pricing Subscription-based
DeploymentOn-premise (integrates into IT environment, scalable from 1 to 30 users).
Mobile AppNot recommended for smartphone viewing (simulations).
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Emergency Medicine, Neurology, Radiology

Support & Reliability

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2024-03-22K232431 510(k)syngo.CT Brain Hemorrhage

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate syngo.CT Brain Hemorrhage

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for syngo.CT Brain Hemorrhage.

View all on YouTube

Frequently Asked Questions

syngo.CT Brain Hemorrhage is an application software program designed to enhance the capabilities of CT imaging systems for evaluating CT datasets, specifically to aid in the detection and differentiation of brain hemorrhages. It helps physicians visualize iodine concentration and distribution in the brain, and can generate virtual non-contrast images from contrast-enhanced dual-energy scans, potentially avoiding the need for a second scan. This AI-based tool assists radiologists in prioritizing cases of suspected intracranial hemorrhage on non-contrast CT examinations of the head by flagging hemorrhages to inform image interpretation and therapy protocols, notify clinicians, and reprioritize radiology worklists.
Clinical benefits include improved diagnostic performance for intracranial hemorrhage (ICH) detection, with studies showing high sensitivity (93.6%) and specificity (96.2%), and an excellent negative predictive value (99.2%). This can lead to workload reduction, especially in understaffed settings, and help prioritize critical cases. However, AI algorithms, including syngo.CT Brain Hemorrhage, are intended for informational purposes only and not for diagnostic use. While effective for overall ICH detection, they may have lower detection rates for specific subtypes of ICH, and can produce false-positive findings due to postoperative defects, artifacts, or tumors. Continuous monitoring is vital as AI performance can drift over time due to evolving clinical practices or equipment variability.
syngo.CT Brain Hemorrhage is a Class II medical device, categorized as radiological computer-assisted triage and notification software. It was authorized by the FDA in January 2022 via the 510(k) pathway. The device's performance has been validated in retrospective studies, demonstrating acceptable sensitivity and specificity to support its claim of substantial equivalence to predicate devices.
While syngo.CT Brain Hemorrhage focuses on CT imaging, other AI-powered solutions are emerging for intracranial hemorrhage detection. Generally, AI algorithms for ICH detection have shown diagnostic accuracy comparable to experienced clinicians. Additionally, non-contrast syngo DynaCT Sine Spin FDCT imaging is being investigated as a potential alternative to conventional multidetector CT for detecting and excluding intracranial hemorrhages in acute stroke patients. The American Heart Association guidelines also recommend non-invasive vascular imaging like CT angiography (CTA) to evaluate for underlying vascular lesions following ICH diagnosis.
syngo.CT Brain Hemorrhage is part of the syngo.via platform, which is designed for advanced PET and CT reading on PACS. syngo.via can be fully integrated into the RIS/PACS workstation of major vendors, overcoming limitations of traditional 2D/3D image display by offering advanced visualization and quantification functionalities. This integration allows for a streamlined workflow from case preparation to reading and sharing, making cases instantly available without network transfers and enabling advanced post-processing tasks to be automated and sent directly to PACS.

Related Tools

syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
Neurophet AQUA AD Plus
Neurophet
Neurology AI
Neurophet AQUA AD Plus is an AI-powered brain imaging analysis software that supports the diagnosis, treatment guidance, and monitoring of Alzheimer's disease by analyzing MRI and PET scans.
myosmart trial kit
Otto Bock Healthcare Products GmbH
Neurology AI
The Ottobock MyoSmart Trial Kit assists clinicians in assessing and fitting advanced neurorehabilitation prosthetic and orthotic solutions.
connectgrip. (560X27-1)
Otto Bock Healthcare Products GmbH
Neurology AI
Otto Bock Healthcare Products GmbH offers advanced prosthetic and orthotic solutions, with 'connectgrip' (560X27-1) likely being a component designed for secure and functional connection within these systems, potentially incorporating intelligent features for enhanced user control.
myosmart.cuff (757M20-2)
Otto Bock Healthcare Products GmbH
Lab & Diagnostics
The myosmart.cuff is a medical device by Otto Bock Healthcare Products GmbH designed for objective measurement of muscle tone, primarily for use in neurological rehabilitation.
myosmart. (13E522)
Otto Bock Healthcare Products GmbH
Neurology AI
myosmart.

See all Neurology AI tools →

More from Siemens Medical Solutions USA

ACUSON Origin Diagnostic Ultrasound System
Siemens Medical Solutions USA, Inc.
Cardiology AI
The ACUSON Origin Diagnostic Ultrasound System by Siemens Healthineers offers AI-powered cardiovascular imaging for enhanced diagnostic confidence and workflow efficiency.
ACUSON Sequoia Diagnostic Ultrasound System
Siemens Healthineers
Radiology & Imaging AI
The ACUSON Sequoia Diagnostic Ultrasound System by Siemens Healthineers is a premium platform featuring BioAcoustic imaging, InFocus technology, and AI-powered tools to deliver consistent, high-resolution ultrasound imaging across diverse patient types and clinical applications.
ACUSON Sequoia Diagnostic Ultrasound System, ACUSON Sequoia Select Diagnostic Ultrasound System, ACUSON Origin Diagnostic Ultrasound System
Siemens Medical Solutions USA
Cardiology AI
Siemens Healthineers offers the ACUSON Sequoia, ACUSON Sequoia Select, and ACUSON Origin ultrasound systems, providing advanced imaging for various medical needs. The Sequoia line focuses on high-resolution imaging with deep penetration and reduced variability, while the AI-powered ACUSON Origin specializes in comprehensive cardiovascular diagnostics and interventions.
ACUSON Sequoia Diagnostic Ultrasound System, ACUSON Sequoia Select Diagnostic Ultrasound System, ACUSON Origin Diagnostic Ultrasound System, ACUSON Origin ICE Diagnostic Ultrasound System
Siemens Medical Solutions, USA
Cardiology AI
Siemens Healthineers offers advanced AI-powered ultrasound systems, including the ACUSON Origin for comprehensive cardiovascular care and the ACUSON Sequoia for high-performance general imaging with BioAcoustic™ technology.

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-14 | First Added: 2026-04-19
AI Tool Finder
AI-powered search. Results may not be comprehensive.